Clinical trial

Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of…

NCT00136370 · Centers for Disease Control and Prevention, U.S. Fed · Unknown status

Key facts

NCT number NCT00136370
Title Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn
Official title Preventing Serious Neonatal and Maternal Peripartum Infections in Developing Country Settings With a High Prevalence of HIV Infection: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa
Lead sponsor Centers for Disease Control and Prevention, U.S. Fed
Collaborators Bill and Melinda Gates Foundation United States Agency for International Development (USAID) U.S. Fed National Vaccine Program Office
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Infant, Newborn, Diseases, Sepsis, Puerperal Infection
Intervention type Drug, Procedure
Interventions Chlorhexidine, Birth canal wipe, sterile water external genital wipe
Enrollment 8,000
Start date Apr 1, 2004
Completion Nov 1, 2007
First posted Aug 29, 2005
Last update posted Sep 24, 2007
Countries South Africa

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies